Your browser doesn't support javascript.
loading
Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition.
Micháliková, Dominika; Tyukos Kaprinay, Barbara; Lipták, Boris; Svík, Karol; Slovák, Lukás; Sotníková, Ruzena; Knezl, Vladimír; Gaspárová, Zdenka.
Affiliation
  • Micháliková D; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava, Slovakia.
  • Tyukos Kaprinay B; Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia.
  • Lipták B; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava, Slovakia.
  • Svík K; Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia.
  • Slovák L; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava, Slovakia.
  • Sotníková R; Department of Pharmacology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia.
  • Knezl V; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava, Slovakia.
  • Gaspárová Z; Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava, Slovakia.
Saudi Pharm J ; 27(8): 1196-1202, 2019 Dec.
Article in En | MEDLINE | ID: mdl-31885479
ABSTRACT

BACKGROUND:

Metabolic syndrome is a cluster of metabolic risk factors. The clear causes of its development are not known yet and there is no comprehensive treatment of this disease. There is a trend to use natural substances in the treatment of various diseases, but their effects need to be well explored. We decided to test effect of rutin compared to the effect of the standard drug atorvastatin.

METHODS:

As a model of metabolic syndrome we used males of hypertriacylglycerolemic rats in combination with high-fat-high-fructose diet. Rutin (100 mg/kg) and atorvastatin (50 mg/kg) were administered orally daily for 5 weeks.

RESULTS:

We determined biochemical parameters from blood HDL-cholesterol, LDL-cholesterol, total cholesterol, triacylglycerols. Relaxation and contraction response of aorta was measured to determine vessel dysfunctions and possible predisposition to cardiovascular disease. The negative influence on cognitive functions could be associated with the development of metabolic cognitive syndrome. Therefore we aimed to monitor spatial memory by Morris water maze test. Both rutin and atorvastatin had a tendency to decrease levels of serum triacylglycerols, but only atorvastatin significantly reduced levels od LDL-cholesterol and increased HDL-cholesterol levels. Both compounds significantly reduced the phenylephrine-induced contractile response of the aorta and improved the relaxation response. Further, treated animals learned better compared to untreated rats in the Morris water maze.

CONCLUSION:

Based on our results we can assume that atorvastatin and rutin had positive effect on spatial memory and vessel reactivity. Atorvastatin optimized lipid profile of blood serum.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Saudi Pharm J Year: 2019 Document type: Article Affiliation country: Slovakia

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Saudi Pharm J Year: 2019 Document type: Article Affiliation country: Slovakia